Rheumatology

Back to articles

IL-17 inhibitors are effective for management of patients with RA

KEY POINT

Results of a meta-analysis published in Clinical Rheumatology showed that use of interleukin-17 (IL-17) inhibitors was safe and effective in patients with rheumatoid arthritis (RA) who were either biologic-naive or had an inadequate response to tumor necrosis factor (TNF) inhibitors.